|
|
Blood, 15 February 2005, Vol. 105, No. 4, pp. 1574-1581.
Prepublished online as a Blood First Edition Paper on October 5, 2004; DOI 10.1182/blood-2004-06-2089.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells
Adriano Boasso,
Jean-Philippe Herbeuval,
Andrew W. Hardy,
Christiana Winkler, and
Gene M. Shearer
From the Experimental Immunology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD; the Institute for Medical Chemistry and Biochemistry, Innsbruck Medical University; and Ludwig Boltzmann Institute of AIDS-Research, Innsbruck, Austria.
Indoleamine-2,3-dioxygenase (IDO) and tryptophanyl-tRNA-synthetase (TTS) are interferon- (IFN-)–inducible enzymes that are responsible for tryptophan degradation and for its use in protein synthesis, respectively. IFN-–induced IDO has immunomodulatory properties in murine and human models. A concomitant increase of TTS has been postulated to protect the IDO-expressing cells from tryptophan catabolism. IDO can be induced in dendritic cells (DCs) by recombinant soluble cytotoxic T lymphocyte antigen-4 (CTLA-4-Fc). We investigated the effects of CTLA-4-Fc on IDO and TTS mRNA expression in human peripheral blood mononuclear cells (PBMCs) and isolated leukocyte subsets. CTLA-4-Fc exposure induced increased IDO and TTS expression in unseparated PBMCs, as well as in monocyte-derived mature DCs. CD4+ T cells isolated from CTLA-4-Fc–treated PBMCs showed increased IDO and TTS compared with untreated cells. CD8+ T cells from CTLA-4-Fc–treated PBMCs expressed increased levels of TTS but not IDO. Pretreatment of PBMCs with CTLA-4-Fc inhibited the activation of CD4+ T cells induced by influenza A virus (Flu) or phytohemagglutinin A (PHA), but had no effect on CD8+ T cells. This is the first report of IDO and TTS regulation by the CTLA-4-B7 system in human CD4+ and CD8+ T cells, and raises the possibility that these 2 tryptophan-modulating enzymes provide an important mechanism for regulating immune responses.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. R. F. Abreu, A. M. Grabiec, S. Krausz, R. Spijker, T. Burakowski, W. Maslinski, E. Eldering, P. P. Tak, and K. A. Reedquist
The Presumed Hyporesponsive Behavior of Rheumatoid Arthritis T Lymphocytes Can Be Attributed to Spontaneous Ex Vivo Apoptosis rather than Defects in T Cell Receptor Signaling
J. Immunol.,
July 1, 2009;
183(1):
621 - 630.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Isaacs
Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future
Rheumatology,
October 1, 2008;
47(10):
1461 - 1468.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Botturi, Y. Lacoeuille, P. Thomas, S. Boniface, M. Reynaud-Gaubert, and A. Magnan
CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients
Eur. Respir. J.,
June 1, 2008;
31(6):
1167 - 1176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Krause, E. Singer, P. I. Darley, J. Klebensberger, M. Groettrup, and D. F. Legler
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO
J. Leukoc. Biol.,
November 1, 2007;
82(5):
1106 - 1114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Boasso, M. Vaccari, A. Hryniewicz, D. Fuchs, J. Nacsa, V. Cecchinato, J. Andersson, G. Franchini, G. M. Shearer, and C. Chougnet
Regulatory T-Cell Markers, Indoleamine 2,3-Dioxygenase, and Virus Levels in Spleen and Gut during Progressive Simian Immunodeficiency Virus Infection
J. Virol.,
November 1, 2007;
81(21):
11593 - 11603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Boasso, J.-P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
Blood,
April 15, 2007;
109(8):
3351 - 3359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Zhu, F. Ji, Y. Wang, Y. Zhang, Q. Liu, J. Z. Zhang, K. Matsushima, Q. Cao, and Y. Zhang
Synovial Autoreactive T Cells in Rheumatoid Arthritis Resist IDO-Mediated Inhibition
J. Immunol.,
December 1, 2006;
177(11):
8226 - 8233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Belladonna, U. Grohmann, P. Guidetti, C. Volpi, R. Bianchi, M. C. Fioretti, R. Schwarcz, F. Fallarino, and P. Puccetti
Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO
J. Immunol.,
July 1, 2006;
177(1):
130 - 137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Fallarino, U. Grohmann, S. You, B. C. McGrath, D. R. Cavener, C. Vacca, C. Orabona, R. Bianchi, M. L. Belladonna, C. Volpi, et al.
The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor {zeta}-Chain and Induce a Regulatory Phenotype in Naive T Cells.
J. Immunol.,
June 1, 2006;
176(11):
6752 - 6761.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Orabona, P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al.
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
Blood,
April 1, 2006;
107(7):
2846 - 2854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
Int. Immunol.,
November 1, 2005;
17(11):
1429 - 1438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-i. Hiraoka, N. Takeuchi, Y. Bian, H. Nakahara, M. Kogo, K. Dunussi-Joannopoulos, S. Wolf, S. Ono, and H. Fujiwara
B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors
Int. Immunol.,
August 1, 2005;
17(8):
1071 - 1079.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
